The biopharmaceutical market within the Japan and Asia-Pacific (JAPAC) region has grown consistently since 2010, specifically for emerging biopharmas (EBPs). In fact, in 2018, 80% of all biopharma pipeline projects in JAPAC were EBPs, accounting for 75% of the total clinical trial volume in the region. This growth benefits contract research organizations, pharma organizations and patients alike, but several factors must be considered for drug development safety and regulatory operations in JAPAC
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Nucleai, GoPath Diagnostics Partner to Power AI-Powered Digital Pathology
What You Should Know:
- Nucleai, a leader in spatial biology and AI, and GoPath Diagnostics, a leading provider of digital pathology and molecular diagnostics, announced a strategic collaboration today.
- The partnership aims to revolutionize clinical trials, diagnostics, and research in oncology and immunology by combining their strengths in AI and real-world data.
Unlocking the Power of Spatial AI Biomarkers
Nucleai specializes in "spatial AI biomarkers." This
Read More
Synchron Launches Patient Registry for Stentrode Brain-Computer Interface
What You Should Know:
- Synchron, a company pioneering brain-computer interface (BCI) technology unveils a community registry that aims to bring together patients with motor impairments, their caregivers, and medical professionals to explore the potential of BCI in restoring lost functionality.
- By uniting patients, caregivers, and medical professionals, this initiative has the potential to revolutionize the way we treat motor impairments and empower individuals to regain control of
Read More
Hartwig Medical, Ultima Genomics Partner to Transform Precision Oncology with Affordable Genetic Testing
What You Should Know:
- Hartwig Medical Foundation, a provider in using comprehensive genetic profiling to improve cancer treatment, and Ultima Genomics, a developer of groundbreaking next-generation sequencing (NGS) technology, announce a groundbreaking collaboration.
- The strategic partnership aims to make whole genome sequencing, the most detailed form of genetic analysis, a more accessible and affordable tool in the fight against cancer.
The Challenge: High Costs Limit
Read More
Culmination Bio, BillionToOne Partner to Validate Cancer Diagnostics
What You Should Know:
Culmination Bio, a data and technology company combining clinical and biospecimen data, announced a partnership with BillionToOne, Inc., a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all.Culmination Bio and BillionToOne are working together to leverage their respective strengths in order to facilitate the development and validation of robust and impactful oncology
Read More
Manifold Secures $15M to Revolutionize Clinical Research with AI
What You Should Know:
- Manifold, an AI-powered clinical research platform raises $15M in a Series A funding round led by TQ Ventures with participation from Calibrate Ventures, SK Ventures, and existing investors TTCER Partners and Dr. Sachin H. Jain.
- By accelerating research progress, Manifold paves the way for faster development of life-saving treatments and improved patient outcomes.
AI-Powered Clinical Research Platform
Manifold tackles a critical challenge in medical
Read More
myTomorrows Partners with brainstrust to Support Brain Cancer Patients in Accessing Clinical Trials
What You Should Know:
myTomorrows, a global health technology company connecting patients with all possible treatment options, today announced a new partnership with brainstrust, a UK-based charity that helps people living with a brain tumor reach their potential and thrive.Under the new partnership, people with brain tumors will be equipped with the means to bolster their knowledge of relevant treatment options, potentially extending to participation in clinical trials and access to
Read More
Nucleai Secures $14M to Enhance Clinical Trial Enrollment with Spatial AI Biomarker
What You Should Know:
- Nucleai, a pioneer in spatial AI biomarkers raises $14M in funding led by M Ventures, the corporate venture arm of Merck KGaA.
- The investment brings Nucleai's total funding to $60M and fuels their mission to transform personalized medicine through AI-powered patient selection for clinical trials.
AI-Driven Spatial Biomarkers
Nucleai's groundbreaking technology deciphers the intricate conversations between cells within tissue samples. By leveraging AI and
Read More
Verix Adds Gen AI Database Explorer to Commercial Pharma Optimization
What You Should Know:
- Verix, a leader in AI-powered commercial operations solutions for the pharmaceutical industry, has announced the launch of its revolutionary GenAI Database Explorer.
- The GenAI-powered tool empowers sales reps with the ability to explore complex commercial data using natural language processing (NLP), marking a significant step forward in data accessibility and insights generation.
Empowering Sales Teams with Natural Language Queries
Verix's flagship
Read More
Pharmacovigilance in Crisis: Automation as the Answer to Workforce Shortages
The healthcare industry is no stranger to workforce shortages, and the pharmaceutical industry may be next to experience disruptions brought on by labor challenges. According to the U.S. Bureau of Labor Statistics, it is estimated that occupations across life, physical and social sciences are expected to grow 7% by 2028. However, statistics also indicate that about 136,800 openings in these fields will remain unfilled annually through 2032, as employment growth and worker resignations are
Read More
